Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells
Stephen L. Abrams, Peter P. Ruvolo, Vivian Ruvolo, et al.
Oncotarget (2017) Vol. 8, Iss. 44, pp. 76525-76557
Open Access | Times Cited: 17

Showing 17 citing articles:

Metformin influences drug sensitivity in pancreatic cancer cells
Saverio Candido, Stephen L. Abrams, Linda S. Steelman, et al.
Advances in Biological Regulation (2018) Vol. 68, pp. 13-30
Closed Access | Times Cited: 48
A1BG-AS1 promotes adriamycin resistance of breast cancer by recruiting IGF2BP2 to upregulate ABCB1 in an m6A-dependent manner
Jian Wang, Jie Xu, Jie Zheng
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Nuclear inositide signaling and cell cycle
Stefano Ratti, Giulia Ramazzotti, Irene Faenza, et al.
Advances in Biological Regulation (2017) Vol. 67, pp. 1-6
Closed Access | Times Cited: 35
Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals
Stephen L. Abrams, Kvin Lertpiriyapong, Li V. Yang, et al.
Advances in Biological Regulation (2018) Vol. 69, pp. 16-34
Closed Access | Times Cited: 35
LncRNA PVT1 contributes to invasion and doxorubicin resistance of bladder cancer cells through promoting MDM2 expression and AURKB‐mediated p53 ubiquitination
Xiaoqin Jiang, Huizhen Li, Fang Yu, et al.
Environmental Toxicology (2022) Vol. 37, Iss. 6, pp. 1495-1508
Closed Access | Times Cited: 17
Effects of berberine, curcumin, resveratrol alone and in combination with chemotherapeutic drugs and signal transduction inhibitors on cancer cells—Power of nutraceuticals
James A. McCubrey, Stephen L. Abrams, Kvin Lertpiriyapong, et al.
Advances in Biological Regulation (2017) Vol. 67, pp. 190-211
Closed Access | Times Cited: 28
Roles of p53, NF-κB and the androgen receptor in controlling NGAL expression in prostate cancer cell lines
William H. Chappell, Saverio Candido, Stephen L. Abrams, et al.
Advances in Biological Regulation (2018) Vol. 69, pp. 43-62
Closed Access | Times Cited: 21
Location-dependent role of phospholipase C signaling in the brain: Physiology and pathology
Isabella Rusciano, Maria Vittoria Marvi, Eric Owusu Obeng, et al.
Advances in Biological Regulation (2020) Vol. 79, pp. 100771-100771
Closed Access | Times Cited: 20
Dual inhibition of PI3K/mTOR signaling in chemoresistant AML primary cells
Jessika Bertacchini, Chiara Frasson, Francesca Chiarini, et al.
Advances in Biological Regulation (2018) Vol. 68, pp. 2-9
Closed Access | Times Cited: 20
Combination of MEK Inhibitor and the JAK2-STAT3 Pathway Inhibition for the Therapy of Colon Cancer
Jianying Jin, Qunyi Guo, Jingjing Xie, et al.
Pathology & Oncology Research (2019) Vol. 25, Iss. 2, pp. 769-775
Closed Access | Times Cited: 19
Wild type and gain of function mutant TP53 can regulate the sensitivity of pancreatic cancer cells to chemotherapeutic drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 pathway inhibitors, nutraceuticals and alter metabolic properties
James A. McCubrey, Akshaya K. Meher, Shaw M. Akula, et al.
Aging (2022) Vol. 14, Iss. 8, pp. 3365-3386
Open Access | Times Cited: 8
Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals
Saverio Candido, Stephen L. Abrams, Linda S. Steelman, et al.
Advances in Biological Regulation (2019) Vol. 72, pp. 22-40
Closed Access | Times Cited: 11
Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells
Shaw M. Akula, Saverio Candido, Stephen L. Abrams, et al.
Advances in Biological Regulation (2019) Vol. 75, pp. 100672-100672
Closed Access | Times Cited: 10
Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-family member expression
Linda S. Steelman, Steve L. Abrams, Peter P. Ruvolo, et al.
Oncotarget (2017) Vol. 8, Iss. 68, pp. 113013-113033
Open Access | Times Cited: 8
Sensitivity of pancreatic cancer cells to chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals can be regulated by WT-TP53
Stephen L. Abrams, Shaw M. Akula, Alberto M. Martelli, et al.
Advances in Biological Regulation (2021) Vol. 79, pp. 100780-100780
Closed Access | Times Cited: 7
Autophagy Promotes Survival of CHP-212 Neuroblastoma Cells Treated With Casiopeínas®
Adriana Vázquez-Aguirre, Anllely Grizett Gutiérrez, Rafael Moreno‐Esparza, et al.
Anticancer Research (2019) Vol. 39, Iss. 7, pp. 3687-3695
Open Access | Times Cited: 6
Effects of rhinacanthin-C in multidrug-resistance breast cancer cells
Suwichak Chaisit
(2019)
Open Access
Page 1

Scroll to top